Quantification of in situ granulation-induced changes in pre-compression, solubility, dose distribution and intrinsic in vitro release characteristics of ibuprofen–cationic dextran conjugate crystanules

Solubility–dissolution correlation for ibuprofen–Ddex conjugate crystanules using artificial neural network (ANN). [Display omitted] The direct effect of intermolecular association between ibuprofen and diethylaminoethyl dextran (Ddex) and the novel ‘melt-in situ granulation–crystallization’ techniq...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2014-08, Vol.471 (1-2), p.453-477
Hauptverfasser: Abioye, Amos Olusegun, Kola-Mustapha, Adeola, Chi, George Tangyie, Ilya, Sunday
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 477
container_issue 1-2
container_start_page 453
container_title International journal of pharmaceutics
container_volume 471
creator Abioye, Amos Olusegun
Kola-Mustapha, Adeola
Chi, George Tangyie
Ilya, Sunday
description Solubility–dissolution correlation for ibuprofen–Ddex conjugate crystanules using artificial neural network (ANN). [Display omitted] The direct effect of intermolecular association between ibuprofen and diethylaminoethyl dextran (Ddex) and the novel ‘melt-in situ granulation–crystallization’ technique on the solubility, dose distribution, in vitro dissolution kinetics and pre-compression characteristics of the ibuprofen–Ddex conjugate crystanules have been investigated using various mathematical equations and statistical moments. The research intention was to elucidate the mechanisms of ibuprofen solubilization, densification and release from the conjugate crystanules as well as its dose distribution in order to provide fundamental knowledge on important physicochemical, thermodynamic and system-specific parameters which are key indices for the optimization of drug–polymer conjugate design for the delivery of poorly soluble drugs. The process of melt-in situ-granulation–crystallization reduced the solubility slightly compared with pure ibuprofen, however, the ibuprofen–Ddex conjugate crystanules exhibited increased ibuprofen solubility to a maximum of 2.47×10−1mM (at 1.25×10−4mM Ddex) and 8.72×10−1mM (at 6.25×10−4mM Ddex) at 25 and 37°C, respectively. Beyond these concentrations of Ddex ibuprofen solubility decreased steadily due to stronger bond strength of the conjugate crystanules. The enthalpy–entropy compensation plot suggests a dominant entropy-driven mechanism of solubilization. In the same vein, the addition of Ddex increased the rate and extent of in vitro ibuprofen release from the conjugate crystanule to 100% within 168h at Ddex concentration of 1.56×10−4mM, followed by a decrease with Ddex concentration. The conjugate crystanules exhibited controlled and extended-complete release profile which appeared to be dictated by the concentration of the Ddex and its strong affinity for ibuprofen. A comparison of the real experimental with the predicted data using artificial neural network shows excellent correlation between solubility and dissolution profiles (average error=0.2348%). Heckel, Kawakita, Cooper–Eaton and Kuno equations were employed to determine the mechanism of densification during tapping process. Ddex in the crystanules consistently improved particle rearrangement in the order of 2.5–7 folds compared with pure ibuprofen and stabilized ibuprofen against fragmentation during tapping process. Primary and secondary particle rearrangements w
doi_str_mv 10.1016/j.ijpharm.2014.05.053
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1541382355</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517314004062</els_id><sourcerecordid>1541382355</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-dcd7af191a3e3215f4fa718c95b94ce7b4ae22f212af8c8b3557dd0f475106b23</originalsourceid><addsrcrecordid>eNqFkd2KFDEQhYMo7rj6CEouvdge89Pp7rkSWXZVWBBBr0M6qcym6UnG_CzOne_ga_kUPonpmdFboaBIcb6qEw5CLylZU0K7N9PaTft7FXdrRmi7JqIWf4RWdOh5w9u-e4xWhPdDI2jPL9CzlCZCSMcof4ouWDsMXbehK_Trc1E-O-u0yi54HCx2HieXC95G5ct8HDfOm6LBYH2v_BbSotlHaHTY1ZZSlVzhFOYyutnlwxU2IQE2LuXoxnJcrLypVH375PTCP7gcA44wg6raujgqnSFWxul09DGWfQwW_O8fP0_uKmjge66-sA5-KluVKxkPKS9OIT1HT6yaE7w490v09fbmy_WH5u7T-4_X7-4azTuRG6NNryzdUMWBMypsa1VPB70R46bV0I-tAsYso0zZQQ8jF6I3hti2F5R0I-OX6PVpb_X3rUDKcueShnlWHkJJkoqW8oFVrkrFSapjSCmClfvodioeJCVyCVJO8hykXIKURNTilXt1PlHGHZh_1N_kquDtSQD1ow8Ookzaga8huQg6SxPcf078Afsouq0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1541382355</pqid></control><display><type>article</type><title>Quantification of in situ granulation-induced changes in pre-compression, solubility, dose distribution and intrinsic in vitro release characteristics of ibuprofen–cationic dextran conjugate crystanules</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Abioye, Amos Olusegun ; Kola-Mustapha, Adeola ; Chi, George Tangyie ; Ilya, Sunday</creator><creatorcontrib>Abioye, Amos Olusegun ; Kola-Mustapha, Adeola ; Chi, George Tangyie ; Ilya, Sunday</creatorcontrib><description>Solubility–dissolution correlation for ibuprofen–Ddex conjugate crystanules using artificial neural network (ANN). [Display omitted] The direct effect of intermolecular association between ibuprofen and diethylaminoethyl dextran (Ddex) and the novel ‘melt-in situ granulation–crystallization’ technique on the solubility, dose distribution, in vitro dissolution kinetics and pre-compression characteristics of the ibuprofen–Ddex conjugate crystanules have been investigated using various mathematical equations and statistical moments. The research intention was to elucidate the mechanisms of ibuprofen solubilization, densification and release from the conjugate crystanules as well as its dose distribution in order to provide fundamental knowledge on important physicochemical, thermodynamic and system-specific parameters which are key indices for the optimization of drug–polymer conjugate design for the delivery of poorly soluble drugs. The process of melt-in situ-granulation–crystallization reduced the solubility slightly compared with pure ibuprofen, however, the ibuprofen–Ddex conjugate crystanules exhibited increased ibuprofen solubility to a maximum of 2.47×10−1mM (at 1.25×10−4mM Ddex) and 8.72×10−1mM (at 6.25×10−4mM Ddex) at 25 and 37°C, respectively. Beyond these concentrations of Ddex ibuprofen solubility decreased steadily due to stronger bond strength of the conjugate crystanules. The enthalpy–entropy compensation plot suggests a dominant entropy-driven mechanism of solubilization. In the same vein, the addition of Ddex increased the rate and extent of in vitro ibuprofen release from the conjugate crystanule to 100% within 168h at Ddex concentration of 1.56×10−4mM, followed by a decrease with Ddex concentration. The conjugate crystanules exhibited controlled and extended-complete release profile which appeared to be dictated by the concentration of the Ddex and its strong affinity for ibuprofen. A comparison of the real experimental with the predicted data using artificial neural network shows excellent correlation between solubility and dissolution profiles (average error=0.2348%). Heckel, Kawakita, Cooper–Eaton and Kuno equations were employed to determine the mechanism of densification during tapping process. Ddex in the crystanules consistently improved particle rearrangement in the order of 2.5–7 folds compared with pure ibuprofen and stabilized ibuprofen against fragmentation during tapping process. Primary and secondary particle rearrangements were the prominent mechanisms of densification while deformation and fragmentation did not occur. Lower concentrations of Ddex below its critical granular concentration (&lt;6.25×10−4mM) hindered plastic deformation and fragmentation, however, the summation of primary and secondary rearrangement parameters was greater than unity suggesting that the overall rearrangement of the conjugate crystanules cannot be explained exclusively by these two steps. This study has demonstrated the formulation of a novel ibuprofen–polymer conjugate which exhibited improved dose distribution and pre-compression characteristics as well as controlled and extended-complete release profiles – a potential drug delivery strategy for poorly soluble drugs.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2014.05.053</identifier><identifier>PMID: 24886691</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage ; Anti-Inflammatory Agents, Non-Steroidal - chemistry ; Crystallization ; DEAE-Dextran - chemistry ; Dose distribution ; Drug Carriers - chemistry ; Drug Liberation ; Ibuprofen - administration &amp; dosage ; Ibuprofen - chemistry ; Mechanism of densification ; Mechanism of dissolution ; Mechanism of solubilisation ; Melt-in situ-granulation–crystallization ; Models, Theoretical ; Neural Networks (Computer) ; Particle Size ; Solubility ; Solubility–dissolution correlation ; Thermodynamics</subject><ispartof>International journal of pharmaceutics, 2014-08, Vol.471 (1-2), p.453-477</ispartof><rights>2014 Elsevier B.V.</rights><rights>Copyright © 2014 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-dcd7af191a3e3215f4fa718c95b94ce7b4ae22f212af8c8b3557dd0f475106b23</citedby><cites>FETCH-LOGICAL-c365t-dcd7af191a3e3215f4fa718c95b94ce7b4ae22f212af8c8b3557dd0f475106b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijpharm.2014.05.053$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24886691$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abioye, Amos Olusegun</creatorcontrib><creatorcontrib>Kola-Mustapha, Adeola</creatorcontrib><creatorcontrib>Chi, George Tangyie</creatorcontrib><creatorcontrib>Ilya, Sunday</creatorcontrib><title>Quantification of in situ granulation-induced changes in pre-compression, solubility, dose distribution and intrinsic in vitro release characteristics of ibuprofen–cationic dextran conjugate crystanules</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>Solubility–dissolution correlation for ibuprofen–Ddex conjugate crystanules using artificial neural network (ANN). [Display omitted] The direct effect of intermolecular association between ibuprofen and diethylaminoethyl dextran (Ddex) and the novel ‘melt-in situ granulation–crystallization’ technique on the solubility, dose distribution, in vitro dissolution kinetics and pre-compression characteristics of the ibuprofen–Ddex conjugate crystanules have been investigated using various mathematical equations and statistical moments. The research intention was to elucidate the mechanisms of ibuprofen solubilization, densification and release from the conjugate crystanules as well as its dose distribution in order to provide fundamental knowledge on important physicochemical, thermodynamic and system-specific parameters which are key indices for the optimization of drug–polymer conjugate design for the delivery of poorly soluble drugs. The process of melt-in situ-granulation–crystallization reduced the solubility slightly compared with pure ibuprofen, however, the ibuprofen–Ddex conjugate crystanules exhibited increased ibuprofen solubility to a maximum of 2.47×10−1mM (at 1.25×10−4mM Ddex) and 8.72×10−1mM (at 6.25×10−4mM Ddex) at 25 and 37°C, respectively. Beyond these concentrations of Ddex ibuprofen solubility decreased steadily due to stronger bond strength of the conjugate crystanules. The enthalpy–entropy compensation plot suggests a dominant entropy-driven mechanism of solubilization. In the same vein, the addition of Ddex increased the rate and extent of in vitro ibuprofen release from the conjugate crystanule to 100% within 168h at Ddex concentration of 1.56×10−4mM, followed by a decrease with Ddex concentration. The conjugate crystanules exhibited controlled and extended-complete release profile which appeared to be dictated by the concentration of the Ddex and its strong affinity for ibuprofen. A comparison of the real experimental with the predicted data using artificial neural network shows excellent correlation between solubility and dissolution profiles (average error=0.2348%). Heckel, Kawakita, Cooper–Eaton and Kuno equations were employed to determine the mechanism of densification during tapping process. Ddex in the crystanules consistently improved particle rearrangement in the order of 2.5–7 folds compared with pure ibuprofen and stabilized ibuprofen against fragmentation during tapping process. Primary and secondary particle rearrangements were the prominent mechanisms of densification while deformation and fragmentation did not occur. Lower concentrations of Ddex below its critical granular concentration (&lt;6.25×10−4mM) hindered plastic deformation and fragmentation, however, the summation of primary and secondary rearrangement parameters was greater than unity suggesting that the overall rearrangement of the conjugate crystanules cannot be explained exclusively by these two steps. This study has demonstrated the formulation of a novel ibuprofen–polymer conjugate which exhibited improved dose distribution and pre-compression characteristics as well as controlled and extended-complete release profiles – a potential drug delivery strategy for poorly soluble drugs.</description><subject>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - chemistry</subject><subject>Crystallization</subject><subject>DEAE-Dextran - chemistry</subject><subject>Dose distribution</subject><subject>Drug Carriers - chemistry</subject><subject>Drug Liberation</subject><subject>Ibuprofen - administration &amp; dosage</subject><subject>Ibuprofen - chemistry</subject><subject>Mechanism of densification</subject><subject>Mechanism of dissolution</subject><subject>Mechanism of solubilisation</subject><subject>Melt-in situ-granulation–crystallization</subject><subject>Models, Theoretical</subject><subject>Neural Networks (Computer)</subject><subject>Particle Size</subject><subject>Solubility</subject><subject>Solubility–dissolution correlation</subject><subject>Thermodynamics</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkd2KFDEQhYMo7rj6CEouvdge89Pp7rkSWXZVWBBBr0M6qcym6UnG_CzOne_ga_kUPonpmdFboaBIcb6qEw5CLylZU0K7N9PaTft7FXdrRmi7JqIWf4RWdOh5w9u-e4xWhPdDI2jPL9CzlCZCSMcof4ouWDsMXbehK_Trc1E-O-u0yi54HCx2HieXC95G5ct8HDfOm6LBYH2v_BbSotlHaHTY1ZZSlVzhFOYyutnlwxU2IQE2LuXoxnJcrLypVH375PTCP7gcA44wg6raujgqnSFWxul09DGWfQwW_O8fP0_uKmjge66-sA5-KluVKxkPKS9OIT1HT6yaE7w490v09fbmy_WH5u7T-4_X7-4azTuRG6NNryzdUMWBMypsa1VPB70R46bV0I-tAsYso0zZQQ8jF6I3hti2F5R0I-OX6PVpb_X3rUDKcueShnlWHkJJkoqW8oFVrkrFSapjSCmClfvodioeJCVyCVJO8hykXIKURNTilXt1PlHGHZh_1N_kquDtSQD1ow8Ookzaga8huQg6SxPcf078Afsouq0</recordid><startdate>20140825</startdate><enddate>20140825</enddate><creator>Abioye, Amos Olusegun</creator><creator>Kola-Mustapha, Adeola</creator><creator>Chi, George Tangyie</creator><creator>Ilya, Sunday</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140825</creationdate><title>Quantification of in situ granulation-induced changes in pre-compression, solubility, dose distribution and intrinsic in vitro release characteristics of ibuprofen–cationic dextran conjugate crystanules</title><author>Abioye, Amos Olusegun ; Kola-Mustapha, Adeola ; Chi, George Tangyie ; Ilya, Sunday</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-dcd7af191a3e3215f4fa718c95b94ce7b4ae22f212af8c8b3557dd0f475106b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - chemistry</topic><topic>Crystallization</topic><topic>DEAE-Dextran - chemistry</topic><topic>Dose distribution</topic><topic>Drug Carriers - chemistry</topic><topic>Drug Liberation</topic><topic>Ibuprofen - administration &amp; dosage</topic><topic>Ibuprofen - chemistry</topic><topic>Mechanism of densification</topic><topic>Mechanism of dissolution</topic><topic>Mechanism of solubilisation</topic><topic>Melt-in situ-granulation–crystallization</topic><topic>Models, Theoretical</topic><topic>Neural Networks (Computer)</topic><topic>Particle Size</topic><topic>Solubility</topic><topic>Solubility–dissolution correlation</topic><topic>Thermodynamics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abioye, Amos Olusegun</creatorcontrib><creatorcontrib>Kola-Mustapha, Adeola</creatorcontrib><creatorcontrib>Chi, George Tangyie</creatorcontrib><creatorcontrib>Ilya, Sunday</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abioye, Amos Olusegun</au><au>Kola-Mustapha, Adeola</au><au>Chi, George Tangyie</au><au>Ilya, Sunday</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantification of in situ granulation-induced changes in pre-compression, solubility, dose distribution and intrinsic in vitro release characteristics of ibuprofen–cationic dextran conjugate crystanules</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2014-08-25</date><risdate>2014</risdate><volume>471</volume><issue>1-2</issue><spage>453</spage><epage>477</epage><pages>453-477</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>Solubility–dissolution correlation for ibuprofen–Ddex conjugate crystanules using artificial neural network (ANN). [Display omitted] The direct effect of intermolecular association between ibuprofen and diethylaminoethyl dextran (Ddex) and the novel ‘melt-in situ granulation–crystallization’ technique on the solubility, dose distribution, in vitro dissolution kinetics and pre-compression characteristics of the ibuprofen–Ddex conjugate crystanules have been investigated using various mathematical equations and statistical moments. The research intention was to elucidate the mechanisms of ibuprofen solubilization, densification and release from the conjugate crystanules as well as its dose distribution in order to provide fundamental knowledge on important physicochemical, thermodynamic and system-specific parameters which are key indices for the optimization of drug–polymer conjugate design for the delivery of poorly soluble drugs. The process of melt-in situ-granulation–crystallization reduced the solubility slightly compared with pure ibuprofen, however, the ibuprofen–Ddex conjugate crystanules exhibited increased ibuprofen solubility to a maximum of 2.47×10−1mM (at 1.25×10−4mM Ddex) and 8.72×10−1mM (at 6.25×10−4mM Ddex) at 25 and 37°C, respectively. Beyond these concentrations of Ddex ibuprofen solubility decreased steadily due to stronger bond strength of the conjugate crystanules. The enthalpy–entropy compensation plot suggests a dominant entropy-driven mechanism of solubilization. In the same vein, the addition of Ddex increased the rate and extent of in vitro ibuprofen release from the conjugate crystanule to 100% within 168h at Ddex concentration of 1.56×10−4mM, followed by a decrease with Ddex concentration. The conjugate crystanules exhibited controlled and extended-complete release profile which appeared to be dictated by the concentration of the Ddex and its strong affinity for ibuprofen. A comparison of the real experimental with the predicted data using artificial neural network shows excellent correlation between solubility and dissolution profiles (average error=0.2348%). Heckel, Kawakita, Cooper–Eaton and Kuno equations were employed to determine the mechanism of densification during tapping process. Ddex in the crystanules consistently improved particle rearrangement in the order of 2.5–7 folds compared with pure ibuprofen and stabilized ibuprofen against fragmentation during tapping process. Primary and secondary particle rearrangements were the prominent mechanisms of densification while deformation and fragmentation did not occur. Lower concentrations of Ddex below its critical granular concentration (&lt;6.25×10−4mM) hindered plastic deformation and fragmentation, however, the summation of primary and secondary rearrangement parameters was greater than unity suggesting that the overall rearrangement of the conjugate crystanules cannot be explained exclusively by these two steps. This study has demonstrated the formulation of a novel ibuprofen–polymer conjugate which exhibited improved dose distribution and pre-compression characteristics as well as controlled and extended-complete release profiles – a potential drug delivery strategy for poorly soluble drugs.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>24886691</pmid><doi>10.1016/j.ijpharm.2014.05.053</doi><tpages>25</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2014-08, Vol.471 (1-2), p.453-477
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_1541382355
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Anti-Inflammatory Agents, Non-Steroidal - administration & dosage
Anti-Inflammatory Agents, Non-Steroidal - chemistry
Crystallization
DEAE-Dextran - chemistry
Dose distribution
Drug Carriers - chemistry
Drug Liberation
Ibuprofen - administration & dosage
Ibuprofen - chemistry
Mechanism of densification
Mechanism of dissolution
Mechanism of solubilisation
Melt-in situ-granulation–crystallization
Models, Theoretical
Neural Networks (Computer)
Particle Size
Solubility
Solubility–dissolution correlation
Thermodynamics
title Quantification of in situ granulation-induced changes in pre-compression, solubility, dose distribution and intrinsic in vitro release characteristics of ibuprofen–cationic dextran conjugate crystanules
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T20%3A06%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantification%20of%20in%20situ%20granulation-induced%20changes%20in%20pre-compression,%20solubility,%20dose%20distribution%20and%20intrinsic%20in%20vitro%20release%20characteristics%20of%20ibuprofen%E2%80%93cationic%20dextran%20conjugate%20crystanules&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Abioye,%20Amos%20Olusegun&rft.date=2014-08-25&rft.volume=471&rft.issue=1-2&rft.spage=453&rft.epage=477&rft.pages=453-477&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2014.05.053&rft_dat=%3Cproquest_cross%3E1541382355%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1541382355&rft_id=info:pmid/24886691&rft_els_id=S0378517314004062&rfr_iscdi=true